Federated Hermes
NXGN

Federated Hermes’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Federated Hermes’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-993
Closed -$16.1K – 2241
2023
Q2 		$16.1K Sell
993
-10,081
-91% -$167K ﹤0.01% 1800
2023
Q1 		$193K Buy
11,074
+9,679
+694% +$174K ﹤0.01% 1587
2022
Q4 		$26.2K Buy
1,395
+405
+41% +$7.8K ﹤0.01% 1782
2022
Q3 		$18K Sell
990
-195
-16% -$3.38K ﹤0.01% 1781
2022
Q2 		$21K Sell
1,185
-43,381
-97% -$827K ﹤0.01% 1762
2022
Q1 		$932K Buy
44,566
+3
+0% +$57 ﹤0.01% 1273
2021
Q4 		$793K Sell
44,563
-1,583
-3% -$25.4K ﹤0.01% 1362
2021
Q3 		$651K Sell
46,146
-28
-0.1% -$436 ﹤0.01% 1432
2021
Q2 		$766K Sell
46,174
-2
-0% -$36 ﹤0.01% 1392
2021
Q1 		$836K Buy
46,176
+3,449
+8% +$68.1K ﹤0.01% 1443
2020
Q4 		$780K Buy
42,727
+8
+0% +$127 ﹤0.01% 1410
2020
Q3 		$544K Sell
42,719
-10
-0% -$128 ﹤0.01% 1456
2020
Q2 		$469K Buy
42,729
+42,399
+12,848% +$439K ﹤0.01% 1490
2020
Q1 		$3K Buy
330
+19
+6% +$245 ﹤0.01% 1996
2019
Q4 		$5K Sell
311
-22
-7% -$364 ﹤0.01% 1966
2019
Q3 		$5K Buy
333
+25
+8% +$416 ﹤0.01% 1960
2019
Q2 		$6K Buy
+308
New +$5.75K ﹤0.01% 1967
2017
Q4 		– Sell
-1,932
Closed -$30K – 2242
2017
Q3 		$30K Sell
1,932
-1,603
-45% -$25.9K ﹤0.01% 1699
2017
Q2 		$60K Buy
3,535
+231
+7% +$3.51K ﹤0.01% 1638
2017
Q1 		$50K Sell
3,304
-409
-11% -$6.02K ﹤0.01% 1630
2016
Q4 		$49K Sell
3,713
-315
-8% -$4.04K ﹤0.01% 1675
2016
Q3 		$46K Sell
4,028
-382
-9% -$4.59K ﹤0.01% 1665
2016
Q2 		$53K Buy
4,410
+810
+23% +$10.9K ﹤0.01% 1659
2016
Q1 		$55K Sell
3,600
-500
-12% -$7.58K ﹤0.01% 1660
2015
Q4 		$66K Buy
+4,100
New +$59.9K ﹤0.01% 1641
2015
Q3 		– Sell
-283
Closed -$5K – 2069
2015
Q2 		$5K Buy
+283
New +$4.56K ﹤0.01% 1803
2013
Q3 		– Sell
-1,272
Closed -$24K – 1785
2013
Q2 		$24K Buy
+1,272
New +$23.2K ﹤0.01% 1648

Other funds holding NXGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Federated Hermes's NXGN Position: Q3 2023 in Review

Federated Hermes sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q3 2023, closing a stake of 993 shares — an estimated $16.1K sold.

Federated Hermes first reported a position in NXGN in Q2 2013 and held it in 27 quarters. The position peaked at $932K in Q1 2022. 214 funds tracked by Wall St. Rank hold NXGN as of Q3 2023.

  • Federated Hermes reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Federated Hermes sold 993 NextGen Healthcare, Inc. Common Stock shares in Q3 2023, an estimated $16.1K.
  • Federated Hermes first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 27 quarters.
  • Federated Hermes's NextGen Healthcare, Inc. Common Stock position peaked at $932K in Q1 2022.
  • 214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.